CStone Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
CStone Pharmaceuticals has a total shareholder equity of CN¥467.7M and total debt of CN¥306.4M, which brings its debt-to-equity ratio to 65.5%. Its total assets and total liabilities are CN¥1.5B and CN¥1.1B respectively.
Belangrijke informatie
65.5%
Verhouding schuld/eigen vermogen
CN¥306.42m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥857.65m |
| Aandelen | CN¥467.66m |
| Totaal verplichtingen | CN¥1.06b |
| Totaal activa | CN¥1.53b |
Recente financiële gezondheidsupdates
Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 03
Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 20Is CStone Pharmaceuticals (HKG:2616) Using Too Much Debt?
Dec 17Recent updates
There's No Escaping CStone Pharmaceuticals' (HKG:2616) Muted Revenues Despite A 29% Share Price Rise
Oct 04Improved Revenues Required Before CStone Pharmaceuticals (HKG:2616) Stock's 27% Jump Looks Justified
May 12Lacklustre Performance Is Driving CStone Pharmaceuticals' (HKG:2616) 28% Price Drop
Mar 04Benign Growth For CStone Pharmaceuticals (HKG:2616) Underpins Stock's 25% Plummet
Jan 18The Market Doesn't Like What It Sees From CStone Pharmaceuticals' (HKG:2616) Revenues Yet As Shares Tumble 26%
Oct 04Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 03Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 20Is CStone Pharmaceuticals (HKG:2616) Using Too Much Debt?
Dec 17Analyse van de financiële positie
Kortlopende schulden: 2616's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥713.2M).
Langlopende schulden: 2616's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥351.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 2616 has more cash than its total debt.
Schuld verminderen: 2616's debt to equity ratio has increased from 0% to 65.5% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 2616 has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: 2616 has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 8.1% each year.